Aug 2026· Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego· Vol 54 4, pp.
526-535
· 0 citations· 35 references
Medicine
TL;DR
In conclusion, altered glutamatergic neurotransmission represents a central mechanism in PTSD pathophysiology and its role in synaptic plasticity, neuronal vulnerability, and network dysregulation highlights its potential relevance as a diagnostic and therapeutic target.
Abstract
Post-traumatic stress disorder (PTSD) is a multifactorial neuropsychiatric condition characterized by persistent disturbances in fear processing, emotional regulation, and memory. Increasing evidence indicates that dysregulation of glutamatergic neurotransmission plays a crucial role in both the development and persistence of PTSD. Glutamate, the primary excitatory neurotransmitter in the central nervous system (CNS), is essential for synaptic plasticity and the formation of traumarelated memories. The aim of this study was to provide an integrated and critical synthesis of current knowledge on glutamatergic dysfunction in PTSD, with particular emphasis on its neurobiological, clinical, and therapeutic implications. This article is a narrative review of the literature published between 2017 and 2025 was conducted. Databases such as PubMed, Scopus, and Web of Science were searched for experimental, clinical, and neuroimaging studies investigating glutamatergic signaling in PTSD. The reviewed studies indicate that chronic stress disrupts glutamate homeostasis, leading to increased extracellular glutamate concentrations and impaired synaptic clearance. These alterations result in excessive activation of ionotropic receptors, particularly N-methyl-D-aspartate (NMDA) receptors and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, promoting calcium influx and neuronal dysfunction. Such processes affect key brain regions, including the amygdala, hippocampus, and prefrontal cortex, contributing to impaired fear extinction and heightened emotional reactivity. Importantly, glutamatergic dysregulation does not occur in isolation but interacts dynamically with neuroinflammatory pathways, altered inhibitory transmission, and dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. In conclusion, altered glutamatergic neurotransmission represents a central mechanism in PTSD pathophysiology. Its role in synaptic plasticity, neuronal vulnerability, and network dysregulation highlights its potential relevance as a diagnostic and therapeutic target. Future research should focus on integrating glutamate-related biomarkers with mechanism-based therapeutic interventions in order to improve diagnostic precision and treatment outcomes in PTSD.
Post-traumatic stress disorder (PTSD) is characterized by persistent traumatic memories and flashbacks, which may arise from dysregulated synaptic plasticity mediated by inflammatory and epigenetic mechanisms. Three intervention strategies are evaluated in this paper. They are exercise and exposure therapy, targeted dr...
Haliya Tian· Theoretical and Natural Scie...· 0 citations
Abstract Background Post-traumatic stress disorder (PTSD) is characterized by hyperarousal of emotional memory, avoidance behaviors, and autonomic instability. It is thought to involve an imbalance in the norepinephrine, dopamine, and serotonin neurotransmitter systems mediated by amygdala hyperactivity and functional...
M. Kawamura, W. Ukai, E. Hashimoto et al.· International Journal of Neu...· 0 citations
A mechanistic framework in which CRF-mediated recruitment of hypothalamic OX neurons contributes to neuroplasticity deficits in the mPFC, HIPP, and AMY is proposed, which positions OX transmission as a potential link between chronic stress and mood-related psychopathology.
Alexa C. E. Alcala, Sophia C. Bellitire, Katherine E. Brunson et al.· Frontiers in Psychiatry· 0 citations
Glutamate, the principal excitatory neurotransmitter in the brain, plays a central role in neurotransmission, synaptic plasticity, and cognitive function. Dysregulation of glutamatergic signaling is implicated in depression, schizophrenia (SCZ), and addiction. N-methyl-Daspartate receptor/α-amino-3-hydroxy-5-methyl-4-...
Wen-Jing Shi, Jie Bai· Actas espanolas de psiquiatr...· 0 citations
A narrative review integrating preclinical and clinical studies investigating glutamatergic mechanisms in mood disorders, focusing on NMDA and AMPA receptor dynamics, intracellular signaling pathways (including mTORC1 and eIF4E-dependent translation), and circuit-level adaptations.
G. Gobbi· International Journal of Neu...· 0 citations
Data indicate that pharmacological modulation of glutamatergic signaling can engage multiple facets of EAE pathophysiology, underscoring a marked translational gap in MS.
E. Stamoula, Theofanis Vavilis, Ioanna Boskou et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.